[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Anti |
| 2. | Perekonnanimi | Kalda |
| 3. | Töökoht | Tartu Ülikool, Farmakoloogia Inst. |
| 4. | Ametikoht | erakorraline dotsent, vanemteadur |
| 5. | Sünniaeg | 23.07.1965 (päev.kuu.aasta) |
| 6. | Haridus | TÜ, arstiteaduskond, ravi, 1991 Meditsiiniteaduste doktor, TÜ, 1999 |
| 7. | Teenistuskäik | 1994 - 1995 (6 kuud) külalis teadur, Karolinska Instituut, Rootsi Kuningriik. 1999 - (4 kuud) külalis teadur, Helsinki Ülikool, Hartman Instituut, Soome Vabariik 1999 – TÜ, Farmakoloogia Inst., teadur (1,0 koormusega) 2001 – 2004 Bostoni Ülikool, Neuroloogia Instituut, Ameerika Ühendriigid, järeldoktorantuur. 2004 - kuni käesoleva ajani TÜ, Farmakoloogia Inst., vanemteadur (0,5 koormusega) ja erak. dotsent (0,5 koormusega). |
| 8. | Teaduskraad | meditsiinidoktor |
| 9. | Teaduskraadi välja andnud asutus, aasta |
Tartu Ülikool, 1999 |
| 10. | Tunnustused | Eesti Vabariigi Teaduspreemia (meditsiin) 2000 a. |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
II Balti Regionaalne Bioloogilise Psühhiaatria Konverents, 31 mai – 2 juuni 2001 Tartu. CINP regionaalse konverentsi (2006) organiseerimiskomitee liige. Eesti Farmakoloogia Seltsi esimees, Eesti Toksikoloogia Seltsi liige. |
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | Peaaju vereringe neurogeenne regulatsioon, hapnik-glükoosi deprivatsiooni poolt indutseeritud apoptootiline neuronite surm ja selle farmakoloogiline preventsioon, adenosiin 2A retseptori antagonistide toime näriliste Huntington’i ja Parkinson’i tõvede mudelites, kromatiini modifikatsiooni osalus kroonilise amfetamiini manustamisest tingitud geenide transkriptsiooni regulatsioonis. |
| 14. | Jooksvad grandid | |
| 15. | Teaduspublikatsioonid |
Fink JS, Kalda A, Ryu H, Stack EC, Schwarzschild MA, Chen JF, Ferrante RJ. Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. J Neurochem. 2004 Feb;88:538-44. Kaasik A, Kalda A, Jaako K, Zharkovsky A. Dehydroepiandrosterone sulphate prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell culture. Neuroscience. 2001;102(2):427-32. Kalda A, Kaasik A, Vassiljev V, Pokk P, Zharkovsky A. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res. 2000 Jan 24;853(2):370-3. Kalda A, Zharkovsky A. Metabotropic glutamate receptor agonists protect from oxygen-glucose deprivation- and colchicine-induced apoptosis in primary cultures of cerebellar granule cells. Neuroscience. 1999;92(1):7-14. Kalda A, Eriste E, Vassiljev V, Zharkovsky A. Medium transitory oxygen-glucose deprivation induced both apoptosis and necrosis in cerebellar granule cells. Neurosci Lett. 1998 Jan 2;240(1):21-4. |
viimati muudetud: 07.08.2005
| Curriculum Vitae (CV) | ||
| 1. | First Name | Anti |
| 2. | Surname | Kalda |
| 3. | Institution | University of Tartu, Department of Pharmacology |
| 4. | Position | docent, senior researcher |
| 5. | Date of birth | 23.07.1965 (day.month.year) |
| 6. | Education | 1991 M.D., University of Tartu, Estonia 1999 Ph.D., University of Tartu, Estonia |
| 7. | Research and professional experience |
1994 – 1995 Visiting researcher, Department of Clinical Neuroscience, Institute of Karolinska, Sweden. 1999 Visiting researcher, Department of Genetics, Institute of Hartman, University of Helsinki, Finland (6 months). 2000 – 2001 Senior researcher, Department of Pharmacology, University of Tartu, Estonia. 2001 – 2004 Postdoctoral Research Fellow, Department of Neurology, Boston University Medical Center, Boston, MA, USA. 2005 – present Senior researcher and docent, Department of Pharmacology, University of Tartu, Estonia. |
| 8. | Academic degree | Ph.D |
| 9. | Dates and sites of earning the degrees |
University of Tartu, 1999 |
| 10. | Honours/awards | Annual Estonian Science Reward (medicine)2000 a. |
| 11. | Research-administrative experience |
Organizer of II Baltic Regional Meeting of Biological Psychiatry, May, 2001. Organizer of CINP Regional Meeting May, 2006. Head of Estonian Society of Pharmacology. Member of Estonian Society of Toxicology. |
| 12. | Supervised dissertations | |
| 13. | Current research program | Apoptosis of neuronal tissue, pharmacology of adenosin A2A receptor, psychostimulant –induced neuronal adaptation. |
| 14. | Current grant funding | |
| 15. | List of most important publications |
Fink JS, Kalda A, Ryu H, Stack EC, Schwarzschild MA, Chen JF, Ferrante RJ. Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. J Neurochem. 2004 Feb;88:538-44. Kaasik A, Kalda A, Jaako K, Zharkovsky A. Dehydroepiandrosterone sulphate prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell culture. Neuroscience. 2001;102(2):427-32. Kalda A, Kaasik A, Vassiljev V, Pokk P, Zharkovsky A. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res. 2000 Jan 24;853(2):370-3. Kalda A, Zharkovsky A. Metabotropic glutamate receptor agonists protect from oxygen-glucose deprivation- and colchicine-induced apoptosis in primary cultures of cerebellar granule cells. Neuroscience. 1999;92(1):7-14. Kalda A, Eriste E, Vassiljev V, Zharkovsky A. Medium transitory oxygen-glucose deprivation induced both apoptosis and necrosis in cerebellar granule cells. Neurosci Lett. 1998 Jan 2;240(1):21-4. |
last updated: 07.08.2005
[ sulge aken ]